Morphological Analysis of the Pineal Gland in Pediatric Retinoblastoma Patients Using Magnetic Resonance Imaging

Retinoblastoma Clinical Trial

Official title:

Morphological Analysis of the Pineal Gland in Pediatric Retinoblastoma Patients Using Magnetic Resonance Imaging

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01884194
• Other study ID #: RTB_0305_outcome
• Status: Completed
• Phase: N/A
• First received: May 24, 2013
• Last updated: December 28, 2015
• Start date: November 2013
• Est. completion date: February 2015

Study information

• Verified date: December 2015
• Source: Charite University, Berlin, Germany
• Contact: n/a
• Is FDA regulated: No
• Health authority: Germany: Ethics Commission
• Study type: Observational

Clinical Trial Summary

MRI is useful for diagnosing pinealoblastoma in retinoblastoma patients

Recruitment information / eligibility

• Status: Completed
• Enrollment: 80
• Est. completion date: February 2015
• Est. primary completion date: December 2014
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A to 50 Years

Eligibility

Inclusion Criteria:

• diagnosis of retinoblastoma

• brain MRI available

Exclusion Criteria:

• insufficient quality of brain MRI

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Pineoblastoma
• Retinoblastoma

Locations

Country	Name	City	State
Germany	Charite Hospital Berlin	Berlin

Sponsors (1)

Lead Sponsor	Collaborator
Charite University, Berlin, Germany

Country where clinical trial is conducted

Germany, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Malignancy criteria of pineal gland	size of pineal gland solid or cystic component (all at baseline)	clinical follow-up 1-year after baseline imaging	No